retatrutide parkinson parkinson's clinical trial Retatrutide Dosing: Early Clinical Trial Insights on How It Might Work Diabetes Dialogue: Retatrutide Reduces Body
Description
The glucagon-like peptide-1 receptor agonist, exendin-4, reduces sexual interaction behaviors in a brain site-specific manner in sexually naive male mice
Glucagon-like peptide-1 or GLP-1 is native to the body and is released from the small intestine after a meal ingestion
The study is ongoing, and new data will be released as it comes in
doi:10.2337/dcS13-2035 32
Diabetes 63(April):32213229
